정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1626 | Not yet recruiting | Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19 | Covid19 | Drug: Baricitinib Drug: Placebo |
Phase 3 | Incepta Pharmaceuticals Ltd | INDUSTRY | 480 | All | 18 Years ~ 80 Years | Dhaka Medical College, Mugda Medical College, Kuwait Bangladesh Friendship Government Hospital, Dhaka, Bangladesh |
| 1625 | Recruiting | EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19 | Respiratory Tract Diseases | Drug: BEVA+SOC Drug: SOC |
Phase 3 | Assistance Publique - Hopitaux de Paris | OTHER | 174 | All | 18 Years | Hopital TENON, Paris, France |
| 1624 | Completed | Efficacy and Safety of Corticosteroids in COVID-19 | Novel Coronavirus Pneumonia | Drug: Methylprednisolone | Not Applicable | Beijing Chao Yang Hospital | OTHER | 86 | All | 18 Years | Hubei province hospital of integrated Chinese & Western Medicine, Wuhan, Hubei, China Yichang first people's Hospital, Yichang, Hubei, China Beijing YouAn Hospital, Beijing, China Renmin Hospital of Wuhan University, Wuhan, China Tianyou Hospital Affiliated to Wuhan University of science and technology, Wuhan, China Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology, Wuhan, China the first peopel hospital of Xiangyang, Xiangyang, China |
| 1623 | Withdrawn | Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia | COVID-19 | Drug: Prednisone Drug: Hydrocortisone |
Phase 3 | University Hospital, Tours | OTHER | 0 | All | 18 Years | |
| 1622 | Completed | Efficacy and Safety of COVID-19 Convalescent Plasma | SARS-CoV 2 | Biological: anti-SARS-CoV-2 convalescent plasma | Not Applicable | Institute for Transfusion Medicine of RNM, University Clinic for Infectious Diseases, North Macedonia | OTHER_GOV | 200 | All | 18 Years | Institute for Transfusion Medicine of RNM, Skopje, North Macedonia |
| 1621 | Recruiting | Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 | Coronavirus | Drug: Darunavir and Cobicistat | Phase 3 | Shanghai Public Health Clinical Center | OTHER_GOV | 30 | All | Shanghai Public Health Clinical Center, Shanghai, Shanghai, China Shanghai Public Health Clinical Center, Shanghai, Shanghai, China |
|
| 1620 | Completed | Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity | Upper Limb Spasticity | Biological: DAXI for injection dose LOW DOSE Biological: DAXI for injection dose MEDIUM DOSE Biological: DAXI for injection Dose HIGH DOSE Other: Placebo |
Phase 2 | Revance Therapeutics, Inc. | INDUSTRY | 83 | All | 18 Years ~ 75 Years | Rancho Research Institute at Rancho Los Amigos National Rehab Center, Downey, California, United States The Parkinsons and Movement Disorder Institute, Fountain Valley, California, United States Collaborative Neuroscience Network LLC, Long Beach, California, United States SC3 Research, Pasadena, California, United States Yale University, Fairfield, Connecticut, United States Waterbury Neurologists, Middlebury, Connecticut, United States Ki Health Partners LLC DBA New England Institute for Clinical Research, Stamford, Connecticut, United States MedStar National Rehabilitation Hospital, Washington, District of Columbia, United States Parkinsons Disease and Movement Disorders Center, Boca Raton, Florida, United States NW FL Clinical Research Group, LLC, Gulf Breeze, Florida, United States Infinity Clinical Research, Hollywood, Florida, United States Parkinsons Disease Treatment Center of Southwest Florida, Port Charlotte, Florida, United States Shirley Ryan AbilityLab, Chicago, Illinois, United States Kansas Institute of Research, Overland Park, Kansas, United States William Beaumont Hospital, Royal Oak, Michigan, United States Rusk Rehabilitation Hospital, Columbia, Missouri, United States Icahn School of Medicine at Mount Sinai, New York, New York, United States Weill Cornell Medical College, New York, New York, United States Carolinas Rehabilitation, Charlotte, North Carolina, United States Wake Forest University School of Medicine, Salem, North Carolina, United States MossRehab, Elkins Park, Pennsylvania, United States University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States Vanderbilt University Medical Center, Nashville, Tennessee, United States North Texas Institute of Neurology and Headache, Frisco, Texas, United States University of Texas Health Science Center at Houston, Houston, Texas, United States University of Utah, Salt Lake City, Utah, United States |